
Francesco Massari: The Prognostic Role of 68Ga-PSMA-PET/CT in Metastatic Hormone-Sensitive Prostate Cancer
Francesco Massari, Medical Oncologist focused on Genitourinary Cancer at The University Hospital of Bologna IRCCS, shared a post on X about recent paper he and colleagues co-authored:
“Out now our last research developed with Andrea Marchetti at University of Bologna.
‘The prognostic role of 68GA-PSMA-PET/CT in metastatic hormone-sensitive prostate cancer: a preliminary analysis.'”
Title: The prognostic role of 68GA-PSMA-PET/CT in metastatic hormone-sensitive prostate cancer: a preliminary analysis.
Authors: Andrea Marchetti, Veronica Mollica, Andrea Farolfi, Gianfilippo Bianciardi, Matteo Rosellini, Elisa Tassinari, Linda Danielli, Lorenzo Bianchi, Riccardo Schiavina, Stefano Fanti, and Francesco Massari
Read The Full Article at Clinical Genitourinary Cancer.
More Posts Featuring Prostate Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023